Scientific and practical journal focused on pharmaceutical industry specialists, managers, companies and research centres involved in the development, preclinical and clinical research, production and promotion of new drugs. The goal of the journal is to formulate among researchers and developers, specialists in regulatory and promotion sphere, a comprehensive vision of the full cycle of drug development taking into account the requirements of proper practices.
Trends in the development of the modern pharmaceutical industry, the transition to personalized medicine, create opportunities for the appearance of gene therapy drugs, biomedical cell products, immunobiological drugs in medical practice, the development of targeted transport systems for new and already known drugs, significantly changing their effectiveness and safety. The creation of new technologies raises a lot of questions for specialists at all stages of drug development (from technological to regulatory), the answers to which are not always found.
Our new journal will combine original research and practical issues, comments from leading industry experts and analysis of Russian and international experience, the development of the regulatory field to become an important source of information for drug developers.
